Nxera Pharma Co Ltd (SOLTF)
9.72
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Nxera Pharma Cash from Operations (TTM): -37.58M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -37.58M |
September 30, 2023 | 10.41M |
June 30, 2023 | 79.15M |
March 31, 2023 | 81.26M |
December 31, 2022 | 76.32M |
September 30, 2022 | 126.03M |
June 30, 2022 | 53.59M |
March 31, 2022 | 59.37M |
December 31, 2021 | 64.66M |
September 30, 2021 | -3.498M |
June 30, 2021 | 20.47M |
March 31, 2021 | 21.88M |
December 31, 2020 | 43.77M |
September 30, 2020 | 13.15M |
June 30, 2020 | 40.70M |
March 31, 2020 | 41.80M |
December 31, 2019 | 31.57M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | -50.71M |
June 30, 2018 | -30.51M |
March 31, 2018 | -19.56M |
December 31, 2017 | 6.692M |
Date | Value |
---|---|
September 30, 2017 | -4.596M |
June 30, 2017 | -10.30M |
March 31, 2017 | 118.88M |
December 31, 2016 | 105.79M |
September 30, 2016 | 146.44M |
June 30, 2016 | 155.03M |
March 31, 2016 | 37.26M |
December 31, 2015 | 40.48M |
September 30, 2015 | 12.05M |
June 30, 2015 | 7.245M |
March 31, 2015 | 0.8413M |
December 31, 2014 | 0.5026M |
September 30, 2014 | 9.654M |
June 30, 2014 | 9.834M |
March 31, 2014 | 3.627M |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-37.58M
Minimum
Dec 2023
126.03M
Maximum
Sep 2022
42.53M
Average
41.80M
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
Takeda Pharmaceutical Co Ltd | 5.353B |
PeptiDream Inc | 88.53M |
Stemcell Holdings Inc | 2.544M |
Healios KK | -20.11M |
AnGes Inc | -- |